A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma
Endometrial cancer (EC) is a common gynecological malignancy and the fourth most common malignancy in European and North American women. Amongst EC, the advanced serous, p53-mutated, and pMMR subtypes have the highest risk of relapse despite optimal standard of care therapy. At present, there is no...
Guardado en:
Autores principales: | Alexandre Harari, Apostolos Sarivalasis, Kaat de Jonge, Anne-Christine Thierry, Florian Huber, Caroline Boudousquie, Laetitia Rossier, Angela Orcurto, Martina Imbimbo, Petra Baumgaertner, Michal Bassani-Sternberg, Lana E. Kandalaft |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54bbe941a68b4cdeb4848cf98f87ab84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: Dyantha I. van der Lee, et al.
Publicado: (2021) -
CORRELACIÓN DE LA HISTEROSCOPIA Y BIOPSIA DIRIGIDA EN EL ESTUDIO DEL ENGROSAMIENTO ENDOMETRIAL PATOLÓGICO POR ULTRASONIDO
por: Socías T,Macarena, et al.
Publicado: (2007) -
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
por: Daniel Delitto, et al.
Publicado: (2021) -
Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Changbo Sun, et al.
Publicado: (2021) -
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
por: Li-Feng Hu, et al.
Publicado: (2021)